Not for clients with type 1 diabetes No history of medullary thyroid carcinoma or MEN 2 syndrome Not currently pregnant or breastfeeding No severe gastrointestinal disease It's easy to get started
Providers differ significantly in terms of support, personalization, accessibility, and patient experience
Do not use Semglee to treat type 2 diabetes in a child of any age
Glucose tolerance improved
Current studies suggest: Tolerance Development Some research subjects develop tolerance to initial side effects, with injection site reactions and systemic effects diminishing over 2-4 weeks of consistent administration
In the context of gastroparesis, certain variants (such as GLP1R rs6923761) may correlate with variable gastric motility response, but this information should be interpreted with a qualified healthcare provider as one factor among manynot as a definitive indicator of medication safety for you